Gene: KIF1C
Official Full Name: kinesin family member 1Cprovided by HGNC
Gene Summary: The protein encoded by this gene is a member of the kinesin-like protein family. The family members are microtubule-dependent molecular motors that transport organelles within cells and move chromosomes during cell division. Mutations in this gene are a cause of spastic ataxia 2, autosomal recessive. [provided by RefSeq, May 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07111 | KIF1C Knockout cell line (HeLa) | Human | KIF1C | 1:3~1:6 | Negative | Online Inquiry |
KO07112 | KIF1C Knockout cell line (HCT 116) | Human | KIF1C | 1:2~1:4 | Negative | Online Inquiry |
KO07113 | KIF1C Knockout cell line (HEK293) | Human | KIF1C | 1:3~1:6 | Negative | Online Inquiry |
KO07114 | KIF1C Knockout cell line (A549) | Human | KIF1C | 1:3~1:4 | Negative | Online Inquiry |
KIF1C Gene Knockout Cell Lines are genetically modified cell lines in which the KIF1C gene has been selectively disrupted, resulting in the complete loss of KIF1C protein expression. This product is pivotal for researchers studying cellular transport mechanisms and the roles of kinesin motor proteins in various biological processes, such as intracellular trafficking, cellular proliferation, and neuronal development. The KIF1C protein, a member of the kinesin superfamily, is known to transport cellular organelles and vesicles along microtubules, and its dysfunction is associated with several diseases, including neurological disorders.
These knockout cell lines function as essential tools for elucidating the pathways and biological implications resulting from KIF1C protein loss. Through their use, researchers can examine the downstream effects of interrupted transport processes, providing insights into cellular homeostasis and signaling mechanisms. The versatility of these cell lines allows for applications in drug discovery, disease modeling, and functional genomics, thereby supporting both basic research and translational studies.
What sets KIF1C Gene Knockout Cell Lines apart from alternatives is their high specificity and reliability, coupled with the thorough validation of KIF1C knockout efficiency, which ensures reproducibility in experimental outcomes. Additionally, these cell lines can be employed in combination with CRISPR technology, enhancing their applicability in precise genetic research.
For researchers and clinicians working on the frontiers of cell biology and pathophysiology, the KIF1C Gene Knockout Cell Lines are invaluable for driving forward our understanding of complex biological systems. By utilizing our product, users can access a robust model for the exploration of both fundamental cellular processes and their implications in disease states. Our company specializes in offering high-quality biological products developed with precision, backed by extensive research expertise, thereby empowering scientists in their quest for groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.